Targeted Therapy for Pulmonary Hypertension in Premature Infants

Pulmonary hypertension (PH) is common in premature infants with bronchopulmonary dysplasia (BPD) and is associated with significant mortality. Despite expert consensus suggesting the use of targeted therapies such as phosphodiesterase inhibitors, endothelin receptor antagonists, and prostanoids, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nees, Shannon N., Rosenzweig, Erika B., Cohen, Jennifer L., Valencia Villeda, Gerson A., Krishnan, Usha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464771/
https://www.ncbi.nlm.nih.gov/pubmed/32824244
http://dx.doi.org/10.3390/children7080097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464771/
https://www.ncbi.nlm.nih.gov/pubmed/32824244
http://dx.doi.org/10.3390/children7080097

Ejemplares similares